Amylin Pharmaceuticals News

CFP: San Diego Chapter of Special Libraries Association SLA-SD Fall Seminar Call for Speakers The San Diego Chapter of the Special Libraries Association is seeking speakers for our annual full-day professional ...

Diabetes is a tough market to compete in for any company. Insulin is the standard therapy for most patients with severe Diabetes.

Corporate raider Carl Icahn has a long history of shaking up companies. Now the 72-year-old billionaire has grabbed a $200 million stake in Amylin Pharmaceuticals, Lilly's partner in the diabetes drug Byetta.

Amylin Pharmaceuticals Inc., Eli Lilly & Co., and Alkermes Inc. reported progress with once-weekly Byetta, generically, exenatide, an adjunct treatment for type-2-diabetes patients who are taking metformin but ...

Amylin Pharmaceuticals, Inc. , Eli Lilly and Company , and Alkermes, Inc. today announced results from a 52-week open label clinical study that showed the durable efficacy of exenatide once weekly, a ...

Amylin Pharmaceuticals Inc. shares tumbled Monday on threats to the company's diabetes drug Byetta and its longer-lasting drug candidate Exenatide LAR.

Drug stocks slipped in early action Tuesday as shares of Amylin Pharmaceuticals were on the rebound after releasing a favorable study on the effectiveness of a long-acting version of its diabetes drug Byetta, ...

Drug stocks moved lower in early trading Monday as shares of Amylin Pharmaceuticals fell on concerns that its diabetes drug Byetta could soon be facing competition from a new drug developed by Danish drugmaker ...

The cafeteria at Infinity Pharmaceuticals is not your average greasy-spoon canteen, says Alex Constan, senior director of toxicology.

IT'S BEEN TWO YEARS since a drug maker has launched new diabetes meds in the US, as several promising treatments stumbled in development.

ADA is one of the largest scientific meetings for endocrinologists and other health care professionals involved in diabetes research and the delivery of diabetes care.

Drug manufacturers are turning their attention to the maintenance problem. The San Diego company Amylin, for example, is testing a drug combination targeted at two of the hormonal signals driving weight regain.

Ford is down 1.4% on a brokerage downgrade after the car company cut earnings estimates.

It's fun to peruse the Form 13-Fs of the most successful investors . Not only can you get investment ideas, but if you're an activist investor, you can get a sneak peek at the next company your favorite ...

Where does 72-year old billionaire investor Carl Icahn get the energy? After prepping for a proxy fight this week with Yahoo! , it was revealed that Icahn bought 6.3 million shares of Amylin Pharmaceuticals in ... via Forbes.com

Investor Carl Icahn bought 6.3 million shares of Amylin Pharmaceuticals in the first quarter of 2008 and also boosted his stake in Biogen Idec Inc during that time period, according to documents Icahn filed ... via Reuters

Amylin Pharmaceuticals Inc. spent $198,000 lobbying the federal government on prescription drug issues in the first quarter of 2008. via MSN Money

Amylin Pharmaceuticals, Inc. will be presenting at the Bank of America Healthcare Conference on Tuesday, May 13, 2008 at 10:00 a.m. PT in Las Vegas. via Freshnews

Amylin Pharmaceuticals, Inc. today announced the initiation of a Phase 2B clinical study evaluating various dosing combinations of pramlintide, an analog of the natural hormone amylin, and recombinant human ... via Freshnews

Companies Featured in This Article: AMYLIN PHARMACEUTICALS, Eli Lilly, Ulta Salon Cosmetics & Fragrance, E*Trade Financial, Lexicon Pharmaceuticals, TRX, Medtox Scientific, RLI, Hill Rom Holdings, Great Lakes ... via Barron's